Ampio Pharmaceuticals, Inc. (AMPE)
Total Valuation
AMPE has a market cap or net worth of $37.03 million. The enterprise value is $8.73 million.
| Market Cap | 37.03M |
| Enterprise Value | 8.73M |
Important Dates
The latest earnings date was Wednesday, May 18, 2022, after market close.
| Last Earnings Date | May 18, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
AMPE has 227.19 million shares outstanding. The number of shares has increased by 15.71% in one year.
| Shares Outstanding | 227.19M |
| Shares Change (YoY) | +15.71% |
| Shares Change (QoQ) | +10.20% |
| Owned by Insiders (%) | 7.98% |
| Owned by Institutions (%) | 21.81% |
| Float | 208.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.66 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.41, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.41 |
| Quick Ratio | 5.22 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -87.40%, which is considered low. The company has a ROIC of -1,129.90%.
| Return on Equity (ROE) | -87.40% |
| Return on Assets (ROA) | -63.10% |
| Return on Capital (ROIC) | -1,129.90% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$952,200 |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.50% in the last 52 weeks. The beta is 1.84, so AMPE's price volatility has been higher than the market average.
| Beta (1Y) | 1.84 |
| 52-Week Price Change | -91.50% |
| 50-Day Moving Average | 0.28 |
| 200-Day Moving Average | 0.57 |
| Average Volume (30 Days) | 3,305,085 |
Short Selling Information
The latest short interest is 23.17 million, so 10.20% of the outstanding shares have been sold short.
| Short Interest | 23.17M |
| Short % of Shares Out | 10.20% |
| Short % of Float | 11.11% |
| Short Ratio (days to cover) | 5.74 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -23.72M |
| Net Income | -19.04M |
| EBITDA | -17.98M |
| EBIT | -19.04M |
| Earnings Per Share (EPS) | -$0.12 |
Balance Sheet
The company has $28.84 million in cash and $533,000 in debt, giving a net cash position of $28.30 million or $0.12 per share.
| Cash & Cash Equivalents | 28.84M |
| Total Debt | 533,000 |
| Net Cash | 28.30M |
| Net Cash Per Share | $0.12 |
| Book Value | 22.25M |
| Book Value Per Share | 0.10 |
| Working Capital | 24.38M |
Cash Flow
In the last 12 months, operating cash flow was -$14.89 million and capital expenditures -$16,000, giving a free cash flow of -$14.90 million.
| Operating Cash Flow | -14.89M |
| Capital Expenditures | -16,000 |
| Free Cash Flow | -14.90M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AMPE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -51.43% |
| FCF Yield | -40.24% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.63% |
| Shareholder Yield | -12.63% |
Analyst Forecast
The average price target for AMPE is $2.55, which is 1,464.42% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.55 |
| Price Target Difference | 1,464.42% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Stock Splits
The last stock split was on August 1, 2008. It was a reverse split with a ratio of 2:7.
| Last Split Date | Aug 1, 2008 |
| Split Type | Reverse |
| Split Ratio | 2:7 |